La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Disease Models, Animal »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Disease Management < Disease Models, Animal < Disease Progression  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 184.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000022 (1999) B. Piallat [France] ; A. Benazzouz ; A L BenabidNeuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease.
000069 (1999) Olga Corti [France] ; Amelia Sánchez-Capelo [France] ; Philippe Colin [France] ; Naïma Hanoun [France] ; Michel Hamon [France] ; Jacques Mallet [France]Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease
000079 (1999) E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E GrossEffect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
000088 (1999) V. Ben [France] ; O. Blin ; B. BruguerolleTime-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions.
000094 (2000) A. Boireau [France] ; P. Dubedat ; F. Bordier ; A. Imperato ; S. MoussaouiThe protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
000098 (2000) P. Damier [France] ; L. Tremblay ; J. Féger ; E C Hirsch[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
000118 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000119 (2000) A. Simon [France] ; C. Savy ; E. Martin-Martinelli ; A. Douhou ; F. Frédéric ; C. Verney ; J. Nguyen-Legros ; R. Raisman-VozariParadoxical increase of tyrosine hydroxylase-immunoreactive retinopetal fibers in the weaver mouse.
000133 (2000) E. Bezard [France] ; M. Jaber ; F. Gonon ; A. Boireau ; B. Bloch ; C E GrossAdaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
000136 (2000) V. Ben [France] ; B. BruguerolleEffects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study.
000172 (????) E C Hirsch [France] ; S. Hunot ; A. HartmannMechanism of cell death in experimental models of Parkinson's disease.
000177 (2001) A. Hartmann [France] ; J D Troadec ; S. Hunot ; K. Kikly ; B A Faucheux ; A. Mouatt-Prigent ; M. Ruberg ; Yves Agid [France] ; E C HirschCaspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.
000179 (2001) H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C HirschCaspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000198 (2001) N. Callizot [France] ; J L Guénet ; C. Baillet ; J M Warter ; P. PoindronThe frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
000202 (2001) E. Bezard [France] ; J M Brotchie ; C E GrossPathophysiology of levodopa-induced dyskinesia: potential for new therapies.
000223 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000240 (2002) Christelle Gouhier [France] ; Sylvie Chalon ; Anne Aubert-Pouessel ; Marie-Claire Venier-Julienne ; Christophe Jollivet ; Jean-Pierre Benoit ; Denis GuilloteauProtection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
000256 (2002) Aïcha Douhou [France] ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid [France] ; Rita Raisman-VozariEffect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice.
000365 (2003) E C Hirsch [France] ; G. Höglinger ; E. Rousselet ; T. Breidert ; K. Parain ; J. Feger ; M. Ruberg ; A. Prigent ; C. Cohen-Salmon ; J M LaunayAnimal models of Parkinson's disease in rodents induced by toxins: an update.
000397 (2003) Jose-Luis González De Aguilar [France] ; Frédérique René ; Luc Dupuis ; Jean-Philippe LoefflerNeuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
000410 (2004) N A Do Thi [France] ; P. Saillour ; L. Ferrero ; J F Dedieu ; J. Mallet ; T. PaunioDelivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Disease Models, Animal" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Disease Models, Animal" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Disease Models, Animal
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024